Guangxi Medical University

Comparison of Partial Stomach-Partitioning and Conventional Gastrojejunostomy for the Treatment of Gastric Outlet Obstruction in Advanced Gastric Cancer

Role: lead

AI Multimodal Model for Liver Cancer Diagnosis and Prognosis

Role: lead

AI Multimodal Model for Predicting CRPC Progression Risk

Role: lead

Intelligent Screening and Precision Diagnosis of Prostate Cancer Based on Multimodal Data

Role: lead

Multimodal Imaging and Digital Pathology for Prostate Cancer Prediction

Role: lead

A Prospective Study of Cadonilimab in Hepatocellular Carcinoma After Radical Surgery With High Risk of Recurrence

Role: lead

Adjuvant TACE in HCC With High-risk Recurrence Factors

Role: lead

Conversion or Neoadjuvant Therapy in Hepatocellular Carcinoma

Role: lead

HAIC Sequential TAE Combined With Lenvatinib and Tislelizumab in Unresectable HCC

Role: lead

PD-1 Inhibitor Plus GP as Neoadjuvant Therapy for Locoregionally Advanced Nasopharyngeal Carcinoma

Role: lead

Induction Chemotherapy With Nab-paclitaxel, Cisplatin and Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma

Role: lead

The Workplace-Based Hypertension Management Program

Role: lead

Artificial Intelligence-assisted Diagnosis

Role: collaborator

A Prospective, Non-interventional Cohort Study of Subsolid Pulmonary Nodules

Role: collaborator

Adjuvant Immune Checkpoint Inhibitors in Postoperative Hepatocellular Carcinoma

Role: lead

Hearing Impairment of Nasopharyngeal Carcinoma

Role: lead

TACE Combined With Tyrosine Kinase Inhibitors and Tislelizumab in Unresectable Hepatocellular Carcinoma

Role: lead

Fruquintinib Plus SOX as Neoadjuvant Therapy for Locally Advanced Gastric Adenocarcinoma

Role: lead

Effect of Smoked Plum and Chewing Gum on Postoperative Bowel Function Following Hepatic Resection

Role: lead

Adjuvant Tislelizumab Plus Lenvatinib for Patients at High-risk of HCC Recurrence After Curative Resection or Ablation

Role: lead